Neoadjuvant Chemotherapy In Advanced Ovarian Carcinoma
Hayam Fathy Mohamed;
Abstract
Ovarian carcinoma is the leading cause of morbidity and mortality from gynecologic malignancy in the U.S. In 2004 the American Cancer Society estimated that approximately 25580 women will be newly diagnosed with ovarian carcinoma, and approximately 16090
Other data
| Title | Neoadjuvant Chemotherapy In Advanced Ovarian Carcinoma | Authors | Hayam Fathy Mohamed | Keywords | Neoadjuvant Chemotherapy In Advanced Ovarian Carcinoma | Issue Date | 2006 | Description | Ovarian carcinoma is the leading cause of morbidity and mortality from gynecologic malignancy in the U.S. In 2004 the American Cancer Society estimated that approximately 25580 women will be newly diagnosed with ovarian carcinoma, and approximately 16090 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.